Gene · 2487
Papers2,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-30 Family: A Novel Avenue for Treating Bone and Joint Diseases? | Int J Med Sci | 2023 | 37057210 | PubTator, text mining | PubMed |
| The history and mystery of sacubitril/valsartan: From clinical trial to the real world. | Front Cardiovasc Med | 2023 | 37057101 | PubTator, text mining | PubMed |
| Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis. | Arthritis Res Ther | 2023 | 37041650 | PubTator, text mining | PubMed |
| Cyclometalated Benzimidazole Osmium(II) Complexes with Antiproliferative Activity in Cancer Cells Disrupt Calcium Homeostasis. | Inorg Chem | 2023 | 37040203 | PubTator, text mining | PubMed |
| Intercellular crosstalk in adult dental pulp is mediated by heparin-binding growth factors Pleiotrophin and Midkine. | BMC Genomics | 2023 | 37024794 | PubTator, text mining | PubMed |
| Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics. | Adv Sci (Weinh) | 2023 | 37017569 | PubTator, text mining | PubMed |
| Plasma Proteomic Associations With Incident Ischemic Stroke in Older Adults: The Cardiovascular Health Study. | Neurology | 2023 | 37015819 | PubTator, text mining | PubMed |
| Identification of five hub immune genes and characterization of two immune subtypes of osteoarthritis. | Front Endocrinol (Lausanne) | 2023 | 37008941 | PubTator, text mining | PubMed |
| The DNA demethylation-regulated SFRP2 dictates the progression of endometriosis via activation of the Wnt/β-catenin signaling pathway. | BMC Mol Cell Biol | 2023 | 36991319 | PubTator, text mining | PubMed |
| Multidisciplinary Approach to Spinal Metastases and Metastatic Spinal Cord Compression-A New Integrative Flowchart for Patient Management. | Cancers (Basel) | 2023 | 36980681 | PubTator, text mining | PubMed |
| Heterogeneity of Cholangiocarcinoma Immune Biology. | Cells | 2023 | 36980187 | PubTator, text mining | PubMed |
| Progress of Wnt Signaling Pathway in Osteoporosis. | Biomolecules | 2023 | 36979418 | PubTator, text mining | PubMed |
| Histology of Type 3 Macular Neovascularization and Microvascular Anomalies in Treated Age-Related Macular Degeneration: A Case Study. | Ophthalmol Sci | 2023 | 36970117 | PubTator, text mining | PubMed |
| Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma. | BMC Oral Health | 2023 | 36966276 | PubTator, text mining | PubMed |
| Testing effects of trigeminal stimulation on binary odor mixture quality in rats. | Front Neurosci | 2023 | 36960175 | PubTator, text mining | PubMed |
| Kidney fibrosis: from mechanisms to therapeutic medicines. | Signal Transduct Target Ther | 2023 | 36932062 | PubTator, text mining | PubMed |
| CD45 Is Sufficient to Initiate Endothelial-to-Mesenchymal Transition in Human Endothelial Cells-Brief Report. | Arterioscler Thromb Vasc Biol | 2023 | 36924233 | PubTator, text mining | PubMed |
| The Safety of Oral Rehydration Solution Jelly for Water and Electrolyte Intake in Patients with Dysphagia. | Ther Clin Risk Manag | 2023 | 36923730 | PubTator, text mining | PubMed |
| Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse. | Nat Cancer | 2023 | 36914817 | PubTator, text mining | PubMed |
| CAF signature predicts the prognosis of colorectal cancer patients: A retrospective study based on bulk RNA sequencing and single-cell RNA sequencing data. | Medicine (Baltimore) | 2023 | 36897717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2487/papers?page=13